Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium-Reference-Cited by-同舟云学术

Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium

Published:2001-08 Issue:8 Volume:133 Page:1330-1338
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Brixius Klara,Bundkirchen Andreas,Bölck Birgit,Mehlhorn U,Schwinger Robert H G

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0704188/fullpdf

Reference27 articles.

1. BEST STEERING COMMITTEE 1995 Design of the Beta-Blocker Evaluation Survival Trial (BEST) Am. J. Cardiol. 75 1220 1223

2. β-Adrenergic receptor blockade in chronic heart failure;BRISTOW;Circulation,2000

3. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in the failing human hearts;BRISTOW;N. Engl. J. Med.,1982

4. Beta1- and beta2-adrenergic receptor subpopulation in nonfailing and failing human myocardium: coupling of both receptor subtypes to muscle contraction and selective beta1-receptor downregulation in heart failure;BRISTOW;Circ. Res.,1986

5. Receptor pharmacology of carvedilol in the human heart;BRISTOW;J. Cardiovasc. Pharmacol.,1992

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β2-Adrenergic Biased Agonist Nebivolol Inhibits the Development of Th17 and the Response of Memory Th17 Cells in an NF-κB-Dependent Manner;2024-09-10

2. The current position of β-blockers in hypertension: guidelines and clinical practice;Current Medical Research and Opinion;2024-04

3. β-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications;Current Medical Research and Opinion;2024-04

4. The β-Blocker Carvedilol and Related Aryloxypropanolamines Promote ERK1/2 Phosphorylation in HEK293 Cells withK_AValues Distinct From Their Equilibrium Dissociation Constants asβ₂-Adrenoceptor Antagonists: Evidence for Functional Affinity;Journal of Pharmacology and Experimental Therapeutics;2023-12-21

5. How carvedilol does not activate β2-adrenoceptors;Nature Communications;2023-11-30